These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26159352)

  • 21. The altered disposition of methamphetamine in the model of methamphetamine-induced neurotoxicity.
    Kitaichi K; Ito Y; Fukuda M; Aoyama N; Nakayama H; Takagi K; Hasegawa T
    Ann N Y Acad Sci; 2004 Oct; 1025():248-56. PubMed ID: 15542724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat.
    Rivière GJ; Byrnes KA; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1220-6. PubMed ID: 10565845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF action.
    Berger V; Richter F; Zettlitz K; Unverdorben F; Scheurich P; Herrmann A; Pfizenmaier K; Kontermann RE
    Protein Eng Des Sel; 2013 Oct; 26(10):581-7. PubMed ID: 24006371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico experiments of single-chain antibody fragment against drugs of abuse.
    Hu G; Chen LY
    Biophys Chem; 2010 Dec; 153(1):97-103. PubMed ID: 21056529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human methamphetamine pharmacokinetics simulated in the rat: single daily intravenous administration reveals elements of sensitization and tolerance.
    Segal DS; Kuczenski R
    Neuropsychopharmacology; 2006 May; 31(5):941-55. PubMed ID: 16123749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of PEGylation and immune complex formation on the pharmacokinetics and biodistribution of recombinant interleukin 10 in mice.
    Alvarez HM; So OY; Hsieh S; Shinsky-Bjorde N; Ma H; Song Y; Pang Y; Marian M; Escandón E
    Drug Metab Dispos; 2012 Feb; 40(2):360-73. PubMed ID: 22083830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining Active Immunization with Monoclonal Antibody Therapy To Facilitate Early Initiation of a Long-Acting Anti-Methamphetamine Antibody Response.
    Hambuchen MD; Carroll FI; Rüedi-Bettschen D; Hendrickson HP; Hennings LJ; Blough BE; Brieaddy LE; Pidaparthi RR; Owens SM
    J Med Chem; 2015 Jun; 58(11):4665-77. PubMed ID: 25973614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanocell targeting using engineered bispecific antibodies.
    Taylor K; Howard CB; Jones ML; Sedliarou I; MacDiarmid J; Brahmbhatt H; Munro TP; Mahler SM
    MAbs; 2015; 7(1):53-65. PubMed ID: 25523746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction and expression of anti-Tn-antigen-specific single-chain antibody genes from hybridoma producing MLS128 monoclonal antibody.
    Yuasa N; Ogawa H; Koizumi T; Tsukamoto K; Matsumoto-Takasaki A; Asanuma H; Nakada H; Fujita-Yamaguchi Y
    J Biochem; 2012 Apr; 151(4):371-81. PubMed ID: 22318767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gestation time-dependent pharmacokinetics of intravenous (+)-methamphetamine in rats.
    White S; Laurenzana E; Hendrickson H; Gentry WB; Owens SM
    Drug Metab Dispos; 2011 Sep; 39(9):1718-26. PubMed ID: 21632964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychoproteomic analysis of rat cortex following acute methamphetamine exposure.
    Kobeissy FH; Warren MW; Ottens AK; Sadasivan S; Zhang Z; Gold MS; Wang KK
    J Proteome Res; 2008 May; 7(5):1971-83. PubMed ID: 18452277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Branched Polymer-Drug Conjugates for Multivalent Blockade of Angiotensin II Receptors.
    Hennig R; Veser A; Kirchhof S; Goepferich A
    Mol Pharm; 2015 Sep; 12(9):3292-302. PubMed ID: 26252154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural characterization of a therapeutic anti-methamphetamine antibody fragment: oligomerization and binding of active metabolites.
    Peterson EC; Celikel R; Gokulan K; Varughese KI
    PLoS One; 2013; 8(12):e82690. PubMed ID: 24349338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological Activity of Mesoporous Dendrimer-Coated Titanium Dioxide: Insight on the Role of the Surface-Interface Composition and the Framework Crystallinity.
    Milowska K; Rybczyńska A; Mosiolek J; Durdyn J; Szewczyk EM; Katir N; Brahmi Y; Majoral JP; Bousmina M; Bryszewska M; El Kadib A
    ACS Appl Mater Interfaces; 2015 Sep; 7(36):19994-20003. PubMed ID: 26305597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into scFv:drug binding using the molecular dynamics simulation and free energy calculation.
    Hu G; Zhang Q; Chen LY
    J Mol Model; 2011 Aug; 17(8):1919-26. PubMed ID: 21110054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
    O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
    Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
    Cho AK; Melega WP; Kuczenski R; Segal DS
    Synapse; 2001 Feb; 39(2):161-6. PubMed ID: 11180503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines.
    Duryee MJ; Bevins RA; Reichel CM; Murray JE; Dong Y; Thiele GM; Sanderson SD
    Vaccine; 2009 May; 27(22):2981-8. PubMed ID: 19428909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactoferrin-conjugated dendritic nanoconstructs for lung targeting of methotrexate.
    Kurmi BD; Gajbhiye V; Kayat J; Jain NK
    J Pharm Sci; 2011 Jun; 100(6):2311-20. PubMed ID: 21491447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers.
    Kaminskas LM; Boyd BJ; Karellas P; Krippner GY; Lessene R; Kelly B; Porter CJ
    Mol Pharm; 2008; 5(3):449-63. PubMed ID: 18393438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.